biomedical research

By Robert Gracy, PhD, CEO of Texas Biomedical Research Institute Now in its eighth decade of existence, the Texas Biomedical Research Institute in San Antonio, Texas, has a mission ’€œto improve the health of our global community through innovative biomedical research.’€ Texas Biomed has a breadth and depth of scientific inquiry coupled with an unparalleled collection of research resources, which in combination provides its researchers unique capabilities. Texas Biomed also views partnering with Research!America ’€“ a strong advocate for growing our country’€™s investment in biomedical funding ’€“ as retaining an effective ally in maintaining and eventually strengthening the backbone of...
Research!America and partners launch national voter education initiative to elevate the priority of medical progress ALEXANDRIA, Va. ’€” April 8, 2014 ’€”Two-thirds of Americans (66%) say it’€™s important for candidates running for office to assign a high priority to funding medical research, according to America Speaks , Volume 14, a compilation of key questions from public opinion polls commissioned by Research!America. Polling shows that Americans place a high value on U.S. leadership in medical innovation, yet only 12% say they are very well informed about the positions of their senators and representative when it comes to their support of medical and scientific research. www...
Excerpt of an article by Research!America VP of Communications Suzanne Ffolkes and Communications Specialist Anna Briseno, published in Elsevier Connect . A panel hosted by Research!America and the Pancreatic Cancer Action Network discusses challenges and opportunities for advancing cancer research Julie Fleshman’s journey to improve outcomes for pancreatic cancer patients was inspired by her father, who died four months after receiving the diagnosis. That was in 1999. Since then, she’s been advocating for research to support early diagnosis and better treatments. “That passion drives me every day ’€“ anger mixed with hope and optimism of the future,” she said. Fleshman , President and CEO...
The House and the Senate have begun deliberations on funding levels for NIH, CDC, AHRQ, NSF and FDA for FY15. Pressure to cut federal spending this midterm election year is enormous, and we need advocates to reach out to their representatives. Members in both houses of Congress are accepting input from constituents on which priorities they should fight for. Let your representatives know that combating disabling and deadly diseases is a national imperative, and funding for the agencies committed to this fight should be included on their list of appropriations priorities. Contact them TODAY and share this alert on Facebook, Twitter and with your networks. Take action!
Excerpt of an op-ed by the Albert and Mary Lasker Foundation President Claire Pomeroy, MD, published in the Huffington Post . As an HIV physician, I began my career early in the AIDS epidemic before effective antiviral medications existed. I held my patients’ hands as they cried when receiving their diagnosis and I went to their funerals. I saw hope in their eyes when new antivirals became available. And when protease inhibitors were licensed and “triple therapy” became the norm, I could help patients plan how they would live, rather than how they would die. Scientific breakthroughs happened only because of our nation’s commitment to biomedical research, but this power of research to make...
By Alan G. Kraut, Executive Director of the Association for Psychological Science In the minds of many people, there is a separation between biomedical research and behavioral research. But that separation is artificial. Behavior is at the core of many health problems. Six out of 10 of the leading causes of premature death, including heart disease, diabetes, and stroke, are linked in part to genetic influences but also to controllable behaviors like physical inactivity, poor diet and smoking. Our 25,000 members are scientists and educators at the nation’€™s universities and colleges, conducting federally funded basic and applied, theoretical, and clinical research. They look at such things...
Letter to the editor by Research!America President and CEO Mary Woolley published in the Philadelphia Inquirer. By visiting a University of Pennsylvania research facility last week, Sen. Bob Casey (D., Pa.) underscored his commitment to making research and innovation an immutable national priority (“Scientists reeling from budget cuts,” Oct. 24). Adequately supported, research will allow us to overcome major health threats and drive the economy. Americans have taken notice that research support is waning and, in addition, say they are concerned that officials in Washington are not paying enough attention to deadly diseases, polling done for our nonprofit advocacy alliance, Research!America...
The Genetics Policy Institute, a Research!America member, will honor the 2013 winners of its Stem Cell Action Awards at the World Stem Cell Summit, which runs December 4-6 in San Diego. The Leadership Award will be given to successful businessmen and noted philanthropists Denny Sanford and Malin Burnham. They are honorary trustees of the Sanford-Burnham Medical Research Institute , of course, but their philanthropy extends far beyond that one institution. The National Advocacy Award will be given to stem cell researcher Paul Knoepfler, PhD, an assistant professor at the University of California, Davis. Knoepfler’€™s blog is a crucial resource for stem cell science and advocacy. (Research!...
Dear Research Advocate: After 16 costly, wasteful days, the government has been funded through January 15 at post-sequestration, FY13 levels ’€” hardly adequate for providing the solutions the American public awaits. A bicameral, bipartisan budget committee has been charged to develop a long-term deficit reduction plan by December 13. If these marching orders sound familiar, they should: We’€™ve been down this road before, only this time sequestration isn’€™t the threat at the end, it’€™s embedded in the negotiations. As tempting as it is to give in to brinksmanship fatigue and just tune out the process, advocates must seize the opportunity to make sure our issue remains front and center,...
Dear Research Advocate: After 16 costly, wasteful days, the government has been funded through January 15 at post-sequestration, FY13 levels ’€” hardly adequate for providing the solutions the American public awaits. A bicameral, bipartisan budget committee has been charged to develop a long-term deficit reduction plan by December 13. If these marching orders sound familiar, they should: We’€™ve been down this road before, only this time sequestration isn’€™t the threat at the end, it’€™s embedded in the negotiations. As tempting as it is to give in to brinksmanship fatigue and just tune out the process, advocates must seize the opportunity to make sure our issue remains front and center,...

Pages

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter